Wende Hutton
General Partner at Canaan
Menlo Park, California
Wende Hutton, General Partner at Canaan is an active investor based in Menlo Park, California. This profile covers what Wende Hutton backs, at which stage, and how founders can reach out in 2026.
- Investor type
- VCPEInvestor
- Stages
- Series ASeries B
- Invests in
- Digital Health & HealthTechMedTech & Medical DevicesBiotech & PharmaHealthcare & Biotech
- Location
- Menlo Park, California
- Typical check
- $2M
- Past investments
- 17
Notable investments
OncoResponse
Apieron
Hyalex OrthopaedicsCalibra MedicalALDEA Pharmaceuticals
Chimerix
ReVision Optics
Butterfly Health
Chrono Therapeutics
Minimally invasive devices
Transcend Medical
DermiraHow to reach Wende Hutton
Angels and operators like Wende Hutton reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded Accelerator.
Connect with Wende Hutton
Frequently Asked Questions
What does Wende Hutton invest in?
Wende Hutton invests in Digital Health & HealthTech, MedTech & Medical Devices, Biotech & Pharma and Healthcare & Biotech, typically at Series A and Series B. Match your sector and stage, then reach out with a personalized pitch.
What stage does Wende Hutton invest at?
Wende Hutton typically invests at Series A and Series B. Lead with traction that fits the stage when you reach out.
What is Wende Hutton's typical check size?
Wende Hutton typically writes checks around $2M. Use it as a signal for whether your raise fits their stage.
How do I contact Wende Hutton?
Unlock Wende Hutton's verified email on Round Funded Accelerator and send a personalized pitch. We surface only deliverable contacts so your outreach lands.